$14.75
+0.02 (+0.14%)
Open$14.74
Previous Close$14.73
Day High$15.74
Day Low$14.69
52W High$36.79
52W Low$5.20
Volume—
Avg Volume262.4K
Market Cap230.16M
P/E Ratio—
EPS$-10.00
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
-72.6% upside
Current
$14.75
$14.75
Target
$4.04
$4.04
$2.50
$4.04 avg
$4.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.62M | 13.81M | 16.40M |
| Net Income | -194,749,710 | -227,984,832 | -3,544,265 |
| Profit Margin | -1,834.5% | -1,742.8% | -21.6% |
| EBITDA | -195,272,451 | -241,296,603 | -3,398,004 |
| Free Cash Flow | — | — | -3,167,900 |
| Rev Growth | -23.1% | -23.1% | +19.8% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |